Cargando…

Dynamic Changes of Lipopolysaccharide Levels in Different Phases of Acute on Chronic Hepatitis B Liver Failure

BACKGROUND: High serum levels of lipopolysaccharide (LPS) with LPS-MD-2/TLR4 complex activated NF-kb and cytokine cause hepatic necrosis in animal models. We investigated the dynamic changes of LPS levels in patients with acute on chronic hepatitis B liver failure (ACHBLF). METHODS: We enrolled ACHB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Calvin, Gu, Yurong, Zhang, Wei, Zheng, Yubao, Peng, Liang, Deng, Hong, Chen, Youming, Chen, Lubiao, Chen, Sui, Zhang, Min, Gao, Zhiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501519/ https://www.ncbi.nlm.nih.gov/pubmed/23185336 http://dx.doi.org/10.1371/journal.pone.0049460

Ejemplares similares

Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment
por: Chen, Lubiao, et al.
Publicado: (2018)

Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure
por: Zhang, Min, et al.
Publicado: (2014)

An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020)

HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression
por: Chen, Lubiao, et al.
Publicado: (2016)

Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)

Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)

Liver myofibroblasts from hepatitis B related liver failure patients may regulate natural killer cell function via PGE2
por: Zhang, Min, et al.
Publicado: (2014)

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
por: Gu, Yurong, et al.
Publicado: (2020)

Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020)

Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment
por: Li, Xiaoyan, et al.
Publicado: (2017)

A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion
por: Chen, Lubiao, et al.
Publicado: (2018)

A novel dynamic model for predicting outcome in patients with hepatitis B virus related acute-on-chronic liver failure
por: Xue, Ran, et al.
Publicado: (2017)

Soluble programmed death‐1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B
por: Zhou, Liang, et al.
Publicado: (2019)

Serum HBV pregenomic RNA exhibited opposite associations with NK(dim) and NK(bright) cell immunity in treatment-naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2021)

Immunological Manifestations of Hepatitis E-Associated Acute and Chronic Liver Failure and Its Regulatory Mechanisms
por: Wu, Jian, et al.
Publicado: (2021)

Prognostic nomogram for acute-on-chronic hepatitis B liver failure
por: Lin, Su, et al.
Publicado: (2017)

Intraperitoneal Administration of Fetuin-A Attenuates d-Galactosamine/Lipopolysaccharide-Induced Liver Failure in Mouse
por: Zhang, Pan, et al.
Publicado: (2014)

GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis
por: Wu, Xiaojuan, et al.
Publicado: (2017)

Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production
por: Wang, Huafeng, et al.
Publicado: (2016)

Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regression
por: ZHENG, ZHEN, et al.
Publicado: (2013)

Crocetin protects against fulminant hepatic failure induced by lipopolysaccharide/D-galactosamine by decreasing apoptosis, inflammation and oxidative stress in a rat model
por: Gao, Ke, et al.
Publicado: (2019)

Metabonomic analysis of liver tissue from BALB/c mice with d-galactosamine/lipopolysaccharide-induced acute hepatic failure
por: Feng, Bo, et al.
Publicado: (2013)

Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure
por: Ha, Jung Min, et al.
Publicado: (2015)

Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively
por: Huang, Biao, et al.
Publicado: (2016)

Prognosis prediction performs better in patients with non-cirrhosis hepatitis B virus-related acute-on-chronic liver failure than those with cirrhosis
por: Yu, Xia, et al.
Publicado: (2022)

Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure
por: Zhao, Qian, et al.
Publicado: (2019)

Dynamic Changes of Clinical Features that Predict the Prognosis of Acute-on-Chronic Hepatitis B Liver Failure: A Retrospective Cohort Study
por: Zheng, Yu-Bao, et al.
Publicado: (2013)

Potential Networks Regulated by MSCs in Acute-On-Chronic Liver Failure: Exosomal miRNAs and Intracellular Target Genes
por: Zhang, Jing, et al.
Publicado: (2021)

RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Chronic Hepatitis and Acute-on-chronic Liver Failure Caused By HBV
por: Chen, Jiajia, et al.
Publicado: (2020)

Ammonia predicts poor outcomes in patients with hepatitis B virus‐related acute‐on‐chronic liver failure
por: Zhang, JinFei, et al.
Publicado: (2020)

Treatment of AECHB and Severe Hepatitis (Liver Failure)
por: Wang, Yu-Ming, et al.
Publicado: (2019)

Dynamic Prognostication in Transplant Candidates with Acute-on-Chronic Liver Failure
por: Lu, Cheng-Yueh, et al.
Publicado: (2020)

Toxic epidermal necrolysis in hepatitis A infection with acute-on-chronic liver failure: Case report and literature review
por: Zang, Xin, et al.
Publicado: (2022)

Review of clinical characteristics, immune responses and regulatory mechanisms of hepatitis E-associated liver failure
por: Chen, Chong, et al.
Publicado: (2022)

Fulminant liver failure model with hepatic encephalopathy in the mouse
por: Hori, Tomohide, et al.
Publicado: (2011)

HBV-related acute-on-chronic liver failure with underlying chronic hepatitis has superior survival compared to cirrhosis
por: Liu, Xiaohui, et al.
Publicado: (2021)

Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure
por: Wu, Cichun, et al.
Publicado: (2023)

SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure
por: Li, Feng, et al.
Publicado: (2023)

Serum IL-21 levels associated with chronic hepatitis B and hepatitis B-related liver failure
por: CHEN, HONG-MEI, et al.
Publicado: (2014)

Conditional survival estimate of acute-on-chronic hepatitis B liver failure: A dynamic prediction based on a multicenter cohort
por: Zheng, Ming-Hua, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_st0sjtokraoou0ogu52eo039mg